Objective: The purpose of the study is to determine safety and efficac
y outcomes of excimer laser photorefractive keratectomy (PRK) for the
treatment of mild-to-moderate myopia. Design: A prospective, multicent
er, phase III clinical trial. Participants: A total of 701 eyes of 701
patients were entered in the study; 612 eyes were examined at 2 years
after surgery. Intervention: Intervention was photorefractive keratec
tomy using the Summit ExciMed UV200LA excimer laser (Summit Technology
, Inc., Waltham, MA). The treatment zone diameter used was 4.5 mm in 2
51 eyes (35.8%) and 5 mm in 450 eyes (64.2%). Attempted corrections ra
nged from 1.50 to 6.00 diopters (D). Main Outcome Measures: Predictabi
lity and stability of refraction, uncorrected and spectacle-corrected
visual acuity, refractive and keratometric astigmatism, corneal haze,
contrast sensitivity, subjective reported problems of glare and halo,
and patient satisfaction were the parameters measured. Results: At 2 y
ears, 407 (66.5%) eyes achieved 20/20 or better uncorrected visual acu
ity and 564 (92.5%) eyes achieved 20/40 or better visual acuity. Three
hundred thirty-six (54.9%) eyes were within 0.5 D and 476 (77.8%) eye
s were within 1.0 D of attempted correction. Stability of refraction i
mproved with time; 86.8% of eyes were stable within 1.0 D from 6 to 12
months, 94% were stable from 12 to 18 months, and 96.3% were stable f
rom 18 to 24 months. There was no evidence of progressive or late myop
ic or hyperopic refractive shifts. One hundred fourteen (18.6%) eyes g
ained 2 or more lines of spectacle-corrected visual acuity, whereas 42
(6.9%) eyes lost 2 or more lines; however, of the latter, 32 (76.2%)
had spectacle-corrected visual acuity of 20/25 or better and 39 (92.9%
) eyes had 20/40 or better. Four hundred forty-two (72.2%) corneas wer
e clear, 138 (22.5%) showed trace haze, 20 (3.3%) mild haze, 9 (1.5%)
moderate haze, and 3 (0.5%) marked haze. On patient questionnaires, 87
(29.7%) patients reported worsening of glare from preoperative baseli
ne; 133 (50.1%) reported worsening of halo symptoms from baseline. Con
clusions: Photorefractive keratectomy appears effective for myopic cor
rections of -1.50 to -6.00 D. Uncorrected visual acuity is maximized i
n most eyes by 3 months, although some patients require between 6 mont
hs and 1 year to attain their best postoperative uncorrected visual ac
uity and some may require from 1 to 2 years for stabilization of refra
ction. Refraction stabilizes progressively without evidence of late my
opic or hyperopic refractive shifts. Optical sequelae of glare and hal
o occur in some patients treated with a 4.5- or 5-mm treatment zone.